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Object. Headache is the most common symptom of both primary and metastatic brain 
tumor, and is generally considered the primary symptom in patients with large pituitary 
adenomas. However, patients with small pituitary adenomas rarely complain of 
intractable headache, and neurosurgeons are unsure whether such small adenomas 
actually contribute to headache. If conventional medical treatments for headache prove 
ineffective, surgical removal of the adenoma can be considered as an alternative 
management strategy. 
Methods. We conducted a retrospective review of 180 patients who underwent 
transsphenoidal surgery (TSS) for pituitary adenomas at Kanazawa University Hospital 
between 2006 and 2014. Patients with acute phase intratumoral hemorrhage were 
excluded. We identified nine patients with intractable headache as the chief complaint 
associated with small pituitary adenoma (diameters 15.8 ± 2.6 mm, 11-20 mm), 
non-functioning in eight, and prolactin-secreting in one. The preoperative 
neuroradiological studies and headache characteristics were assessed retrospectively, 
and the intrasellar pressure evaluation was performed during TSS in the last seven 
patients. 
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Results. All nine patients had complete or substantial resolution of their formerly 
intractable headache after TSS. Headaches consisted of ocular pain ipsilateral to the 
adenoma localization within the sella in four cases and bifrontal headache in five. 
Magnetic resonance imaging of these patients revealed small diaphragmatic foramen, 
which were so narrow that only the pituitary stalk could pass. Computed tomography 
scans showed ossification beneath the sellar floor in the sphenoid sinus, presellar type 
in six cases, and choncal type in three. The adenomas included cysts in seven cases. 
There was no cavernous sinus invasion. Intrasellar pressure measurements averaged 
41.5 ± 8.5 mmHg, range 34-59, significantly higher than in control patients without 
headache (n = 12), namely 22.2 ± 10.6 mmHg (16-30). 
Conclusion. In this study, the authors demonstrated the validity of TSS in the treatment 
of intractable headache associated with pituitary adenoma. The presence of ocular pain, 
especially ipsilateral to the adenoma, integrity of the diaphragm sella, and ossification in 
the sphenoid sinus, cyst or hemorrhage and the absence of cavernous sinus invasion 
were the indications for TSS for patients complaining of intractable headache and 
having pituitary adenomas. 
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Introduction 
   The exact mechanism of headache in patients with pituitary adenoma remains 
unclear [1,2,3]. The widespread availability of advanced neuroradiological instruments 
has increased the chances of detecting patients with both pituitary adenoma and 
headaches. Headache is one of the major symptoms of pituitary adenoma, with a 
prevalence of 33-72%, although neurosurgeons occasionally cannot decide whether the 
pituitary adenoma causes the headache [4,5]. If the conventional medical treatment 
(multiple regimens, such as non-steroidal anti-inflammatory drugs, triptans, and 
antidepressant) proves ineffective, it would be necessary to make final decisions on 
whether to operate for the pituitary adenoma [6,7]. 
    The factors contributing to the induction of headache in patients with pituitary 
adenoma are likely as follows; 1) compression or stretch of vessels and dural structures 
at the base of the brain, 2) increased sellar pressure, and 3) hormonal hypersecretion 
[1,3,8]. Among these factors, we focused on compression or stretch of the diaphragm 
sellae and the medial wall of cavernous sinus, the presence of cyst or hematoma in the 
adenoma, and ossification in the sphenoid sinus. In addition, intrasellar pressure (ISP) 
was measured intraoperatively. 
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Methods 
   This study was approved by the Kanazawa University Institutional Review Board. In 
this retrospective clinical study, 180 patients who underwent transsphenoidal surgery 
(TSS) for pituitary adenomas between 2006 and 2014 at Kanazawa University Hospital 
were reviewed. 5 patients with acute-phase intratumoral hemorrhage were excluded 
due to possible confounding factors. Among 22 patients with chronic type headache 
(12.2%), nine suitable patients who had complained of intractable headache were found 
in the clinical database. Pituitary adenoma had been detected in the patients by 
magnetic resonance imaging (MRI). All these patients had taken a conventional medical 
treatment for their headache, with no sign of improvement. We compiled the following 
items from their clinical charts: sex, age, and headache characteristics (laterality, site, 
severity, quality, frequency, duration, associated symptoms, etc.). Informed consent for 
reviewing all their clinical data was obtained from all seven patients presented in this 
paper. 
Headache evaluation 
   Headache was assessed by the Headache Impact Test version-6 (HIT-6), which was 
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produced by the Shun-ichi Fukuhara and Glaxo Smith Kline Group of companies, and 
was administered by one of the authors [9,10]. This test can evaluate the impact of 
patients’ headaches on their social activities. If the sum of the response scores for six 
questions was 50 or more, a considerable impact on daily living due to headache was 
assumed. 
Neuroradiological evaluation 
   We utilized a 3.0-tesla MRI (GE Health care Japan Corp., Tokyo) to obtain coronal 
and sagittal images, before and after gadolinium administration. Neuroradiological 
evaluation was undertaken as follows. Tumor characteristics (maximum diameter, 
diameter of the diaphragmatic foramen, cavernous sinus invasion, and presence of 
intratumoral cyst) were evaluated by MRI signal intensity on both T1 and T2 weighted 
images. The integrity of dura mater at the diaphragm sellae and the medial wall of the 
cavernous sinus were evaluated on T2-weighted images or Fast Imaging Employing 
Steady State Acquisition (FIESTA) [11]. The diameters of the diaphragmatic foramen 
were measured on the coronal section including the pituitary stalk. The ossification of 
the sphenoid sinus was evaluated on the coronal and sagittal sections of the computed 
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tomography (CT) scan. 
Endocrinological evaluation 
   An endocrinological study was performed preoperatively, and included determination 
of plasma growth hormone, insulin-like growth factor-I, prolactin, adenocorticotrophic 
hormone (ACTH), cortisol, thyroid-stimulating hormone, triiodothyronin, thyroxin, 
lutenizing hormone, and follicle stimulating hormone. After TSS, corticotropin-releasing 
hormone (CRH), thyrotropin-releasing hormone, and luteinizing hormone-releasing 
hormone loading tests were carried out for reserve capacity evaluation of each hormone 
tested preoperatively. 
Measurement of Intrasellar Pressure 
   In the last seven patients, intraoperative intrasellar pressure (ISP) was measured 
using intracranial pressure monitoring sensors (Codman, CA, USA). Briefly, the 
procedure was as follows [12,13]: an incision was made through bone and dura to admit 
the sensor into the adenoma. The length of these incisions was 3 mm. The depth of 
insertion of the sensor into the adenoma was 5 mm. The measured pressure was 
displayed on a monitor. Control ISPs were obtained from another 12 patients harboring 
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pituitary adenoma but without intractable headache. Paired Student’s t-test was used for 
comparison between ISP before and after the removal of sellar floor, and between before 





   Of the nine patients reviewed, three were male and six were female, and the mean 
age was 47.1 (22-63) years. Eight patients had non-functioning adenomas, and one had 
a prolactinoma. The mean period since onset of headache was 1.7 years. The patient 
with prolactinoma had taken cabergoline, but became intolerant to it after three months, 
then consulted to our department when the headache did not resolve with painkillers.  
Headache characteristics 
   Retro-ocular pain ipsilateral to adenoma localization within the sella was found in 
four patients, and frontal headache with retro-ocular pains on both sides was found in 
five. Their headaches severity was severe in five patients and moderate in four. The 
pain qualities were dull in four and pressure in five. All patients had received 
conventional pharmacological treatment and had had no improvement. The average 
total HIT-6 score was 63.3 (54-72), which meant that their headaches had a great 
influence on their daily and social lives. However, postoperatively, eight patients said the 
headaches were gone, and one said his headache was almost gone. The HIT-6 scores 
were 36 in eight and 40 in one (Table 1). 
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Neuroradiological findings 
   The mean size of the tumors present in our study was 15.8 ± 2.6 mm. Seven 
patients had a cyst in the tumor, where the signal was almost iso-intense with CSF. The 
cyst signals contained hypo-intensities on T2 weighted-images, suggesting old 
hemorrhages. The other two adenomas present in this study were solid without a cyst. 
Cavernous sinus invasion was evaluated by Knops classification on the MRI coronal 
sections. The result was grade 2 in two case, grade 1 in three cases, and grade 0 in four 
cases, all of which indicated no obvious tumor invasion into the cavernous sinus. The 
signals of the tumors themselves were hypo-intense in three cases and iso-intense in 
six cases on T1-weighted images, and were hyper-intense in all nine cases in 
T2-weighted images. 
   The maximum diameters of the diaphragmatic foramen were 3.72 ± 1.15 mm on 
average. The diameters of the foramen were so narrow that only the pituitary stalk could 
pass. Remarkable ossification of the sphenoid sinus was detected in all seven patients, 
the conchal type in three and presellar type in six, suggesting the presence of at least 
some extent of ossification beneath the sellar floor in all the patients (Table 2).  
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Intrasellar pressure measurement 
   The average ISP in these seven patients was 41.5 ± 8.5 mmHg (34-59), which is 
much higher than in the patients without headache (12 patients) namely 22.2 ± 10.6 
mmHg (16-30; n = 12, p-value < 0.01) (Table 3). ISP decreased remarkably after sellar 
floor removal being 25.3 ± 7.9 mmHg (17-42) (p-value < 0.01). However, ISP during 
the Valsalva maneuver did not any change being 39.6 ± 7.0 mmHg (31-53) before 
sellar floor removal and 26.3 ± 6.3 mmHg (19-39) (statistically not significant).  
Endocrinological findings 
   The endocrinological examination described above was performed in all nine 
patients in this study. All patients showed hyperprolactinemia, which could be accounted 
for by a sectioning effect on the pituitary stalk in five patients and the presence of 
prolactin-producing adenoma in one (Table 1). Both cortisol and ACTH were decreased 
at baseline, and hyporesponse to CRH loading was observed in two patients (patients 1 
and 3). The hyperprolactinemia of the five patients with non-functioning adenoma was 
normalized after removal of tumor by TSS, and that of the one patient with prolactinoma 
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   Neurosurgeons occasionally have difficulty in determining whether pituitary lesions 
demonstrated on MRI are responsible for the headache or whether pituitary lesions 
together with headaches should be considered a simple co-incidence [1,7]. Although 
the clinical characteristics of headaches in pituitary tumor cases are extremely variable, 
Fleseriu et al. found that chronic daily headaches and self-reported migraines 
represented 75% of these cases, surpassing other types of headaches [1,5]. 
   Headache from brain tumor is generally related to traction and displacement of 
intracranial pain-sensitive structures such as blood vessels, cranial nerves, and dura 
mater [1,8]. Inflammation involving pain-sensitive structures, meningeal irritation, 
meningeal involvement in spreading tumor, psychological causes, and biochemical 
causes have all been described as factors associated with the development of 
headache [6]. Pituitary tumors may provoke headache directly by a mechanical 
mechanism, either by eroding laterally into the cavernous sinus where they irritate the 
first and second divisions of the trigeminal nerve, or by involving the dural lining of the 
sella turcica or diaphragm of the sella, also innervated by the trigeminal nerve, or by an 
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increase in intracranial pressure causing dural stretch [1,4]. In our study, four patients 
complained of retro-ocular pains lateralized to the same side as the adenomas, 
suggesting local stretching of the diaphragm sellae and the medial wall of the cavernous 
sinus might have been present. 
   In order to elucidate the factors contributing to pituitary adenoma-associated 
headache, we focused on cystic lesion within the adenoma, erosion or invasion of the 
medial wall of the cavernous sinus, narrow diaphragm foramen through which only the 
pituitary stalk could pass, ossification of the sphenoidal sinus, and intrasellar pressure. 
The cavernous sinus contains pain-sensitive structures, such as the internal carotid 
artery, the trigeminal nerve, and its ganglion. Therefore, invasion of the cavernous sinus 
might be expected to cause headache [1,8]. However, Levy and Abe emphasized that 
large size of the pituitary tumors and cavernous sinus invasion are not essential in the 
development of headaches associated with pituitary adenomas [2,4]. And Levy also 
addressed the one of the accepted mechanisms for headache is dural stretch, because 
his results from big series study did not show clear association between cavernous 
sinus invasion and headache [14]. In our cases, the sizes of all adenomas were rather 
 16 
small, less than 20 mm, and no apparent cavernous sinus invasion could be found.  
   If a pituitary adenoma extends superiorly or laterally, enlargement of the foramen of 
the diaphragm sellae or interruption of the medial wall of the cavernous sinus would 
occur. These two breakdowns of the dural component around the sella would suggest 
that increases ISP would be compensated (i.e., ISP would not build up). Therefore, we 
judge that a narrow foramen of diaphragm sellae and an intact medial wall of the 
cavernous sinus could induce ISP build-up and consequent dural stretching, leading to 
headache pain. Destrieux et al. reported that e diameter of the diaphragmatic foramen 
is usually more than twice the diameter of the hypophyseal stalk [15]. Thus, the foramen 
diameters of the defect in our nine cases were narrower than what is considered normal. 
In our study, removal of sellar floor made the ISP decrease remarkably, indicating higher 
ISP was relieved with the procedure. Moreover, the Valsalva maneuver did not 
significantly change ISP, suggesting that transmission of increased intracranial pressure 
was blocked by the narrowing defect of the foramen. ISP measurement in patients 
undergoing TSS for pituitary adenoma was pioneered by Lees et al [16,17]. They 
reported that their results are correlated with the radiological and endocrinological 
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features of the adenomas. And they proposed a hypothesis to explain the mechanism of 
hyperprolactinemia associated with the pituitary stalk compression syndrome. 
   The observation of ossification of the sphenoid sinus, whether of choncal or 
presellar type, in all of our nine cases was surprising. To our knowledge, there are no 
previous reports of a relationship between headache and ossification of the sphenoid 
sinus in the patients with pituitary tumors. In theory, the ossification may function as a 
blockade factor allowing ISP buildup in cases with pituitary adenomas. Ramakrishnan et 
al. reported that certain aspects of the sphenoid sinus anatomy might function to resist 
pituitary tumor growth into the sphenoid sinus, which may facilitate an oppositely 
directed suprasellar extension of the tumor [18,19]. Ossification of the sphenoid sinus of 
choncal or the presellar type, is accompanied by massive ossification beneath the sellar 
floor. Therefore, in these cases, the adenomas would tend to extend in the suprasellar 
direction, leading to diaphragm foramen narrowing and subsequent stretching of the 
diaphragm sellae, thus causing severe pain or headache. 
   Pituitary tumor volume has been reported to be one of the major factors to 
correlating with headache. Gondim et al. studied the statistical associations between 
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presence of headache and tumor size, optic compression, sellar destruction and 
cavernous sinus invasion, concluding an association between tumor extension and 
symptom severity [3,12]. However, in that study, the majority of the patients (81.2%) 
had macroadenoma and a large mean tumor size of 24.6 ± 15.1mm [8]. These results 
are inconsistent with the present study where the adenomas were relatively small (15.8 
± 2.6 mm). This can be reconciled if the integrity of anatomical structures surrounding 
the sella turcica plays a deciding role in the development headache associated with 
pituitary tumors.  
   Seven out of nine patients showed cystic changes in their adenomas, suggesting a 
chronic phase of intratumoral hemorrhage that was verified by the presence of an area 
of hypo-intensity area on the T2* images. An important factor in the development of 
headache is a rapid increase in tumor size, whether by tumor growth or by intratumoral 
hemorrhage, which can deform the sellar wall. It is reasonable to suppose that the 
change of tumor size caused by the intratumoral hemorrhage would induce dural stretch 
around small pituitary adenomas, resulting in severe and chronic headache. Indeed, it 
has been reported that the ISP of the macroadenoma confined into the sella, without 
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destruction of the floor and with integrity of the diaphragm sellae, is higher than that of 
tumors with extrasellar extension [8,20]. In our series, usual endoscopic TSS for the 
pituitary adenomas were performed as final treatment, and the symptoms of all patients 
were remarkably relieved as shown by the scores of postoperative HIT-6. I believe 
removal of the tumor in the semi-closed intrasellar cavity like our series is the most 
effective treatment. 
   Endocrinological examination showed hyperprolactinemia in six of our patients. Five 
of these cases were supposed to have been caused by the sectioning effect of the 
pituitary stalk caused by the elevated ISP, and the remaining case was due to the 
constitutively prolactin-producing adenoma. However, even in the patients with 
prolactinoma, the intraoperative ISP was relatively high and therefore the pituitary 
stalk-sectioning effect of high ISP might have contributed to the hyperprolactinemia. 
   In conclusion, a structural barrier was found around the sellar turcica in our study 
group, made up of a small foramen of the diaphragm sellae superiorly, an intact medial 
wall of the cavernous sinus laterally, and ossification in the sphenoid sinus inferiorly. All 
these factors, recognized on MRI, may have contributed to confining the adenoma to 
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the sellar region and increasing ISP. The cystic changes, as well as this structural 
barrier, may be associated with intractable headache in patients with pituitary adenoma. 
It is also important for decision-making to know the character of the headache, and 
ocular pain lateralized to the same side as the adenomas is key to recognizing a 
relationship between headache and adenoma. Such a confined pituitary adenoma with 
intractable headache is a good candidate for TSS. 
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List of Abbreviations 
ACTH; adrenocorticotropin hormone 
CRH; corticotropin-releasing hormone 
CT; computed tomography 
FIESTA; fast imaging employing steady state acquisition 
HIT; headache impact test 
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MRI; magnetic resonance imaging 
PRL; prolactin 
TSS; transsphenoidal surgery 
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Figure 1. Coronal-section magnetic resonance images (MRI) with contrast agent and 
T1 weighted-image (WI) show the pituitary adenomas involving cysts stretching of both 
the diaphragma sellae and the medial wall of the cavernous sinus. (upper line left to 
right; case 1 to 4, lower line left to right; case 5 to 7) 
 
Figure 2. Coronal-section of MRI with T2-WI or FIESTA shows that the diaphragma 
sellae is delineated by a line of hypo-intensity and is stretched by the adenomas, and 
their foramens are so narrow as to pass only the pituitary stalk. Cases are arranged as 
in Fig.1. 
 
Figure 3. Computed tomography (CT) scan, sagittal section with bone image revealing 
ossification beneath the sellar floor of either presellar type or choncal type. Cases are 





Table 1. Characters of headache presented by nine patients with pituitary adenomas in 
this study. 
HIT: headache impact test 
 
Table 2. Characters of preoperative MRI findings demonstrated by nine patients with 
pituitary adenomas in this study. 
CS: cavernous sinus, MRI: magnetic resonance imaging, PRL: prolactin 
 
Table 3. Results of intrasellar pressures measured by intracranial pressure monitor 
sensor intraoperatively. 
Figure 1 Yasuhiko Hayashi 
1 2 3 4 5 
6 7 8 9 case 
Figure 2 Yasuhiko Hayashi 
1 2 3 4 5 
6 7 8 9 case 
Figure 3 Yasuhiko Hayashi 
1 2 3 4 5 
6 7 8 9 case 
Table 1 
         
          
          
Patients Age Sex 
Character of 





      
(years) (preope) (postope) resolved 
1 59 F ocular pain pressure + 1.5 60 36 resolved 
2 63 F ocular pain dull + 0.5 64 36 resolved 
3 57 M ocular pain pressure + 3 72 40 improved 
4 58 M ocular~frontal pain dull - 2.5 56 36 resolved 
5 41 F ocular~frontal pain dull + 1.5 68 36 resolved 
6 38 F ocular~frontal pain pressure - 0.8 66 36 resolved 
7 44 F ocular~frontal pain dull - 3 54 36 resolved 
8 54 M ocular~frontal pain pressure - 2 64 36 resolved 




          
           
           Patients Adenoma Size MRI 
 
Cyst Diaphragma Foramen CS invasion Sphenoid Sinus PRL(ng/mL) 
 
  
 (mm) T1 T2 
 
 (mm) (Knosp) Ossification (preope) (postope) 
1 Non-functioning 16 hypo hyper + 3.3 0 conchal 63.1 13.8 
2 Non-functioning 16 iso hyper + 3.8 0 conchal 18.6 10.4 
3 Non-functioning 11 hypo hyper + 2.5 0 presellar 26.8 10.9 
4 Non-functioning 18 hypo hyper - 3.6 1 presellar 32.8 17.5 
5 PRL producing 14 iso hyper + 2.1 1 conchal 114.7 44.4 
6 Non-functioning 18 iso hyper + 3.7 2 presellar 52.4 5.9 
7 Non-functioning 17 iso hyper + 3.8 2 presellar 104.8 22.9 
8 Non-functioning 20 iso hyper + 4.3 1 presellar 11.7 10.3 





   Patients Intrasellar pressure (mmHg) 
 
 
before sellar floor removal after sellar floor removal 
1 - - 
2 - - 
3 47   (46) 26   (25) 
4 59   (52) 42   (39) 
5 34   (36) 24   (27) 
6 36   (37) 24   (27) 
7 40   (39) 25   (24) 
8 44   (45) 20   (22) 
9 36   (31) 17   (19) 
 
(during Valsalva maneuver) 
  
